| N0 (N=507) |
N1 (N=174) |
N2 (N=92) |
N3 (N=1) |
P-value | |
|---|---|---|---|---|---|
| pathologic_T | |||||
| T1 | 182 (35.9%) | 34 (19.5%) | 14 (15.2%) | 1 (100%) | <0.001 |
| T2 | 249 (49.1%) | 112 (64.4%) | 58 (63.0%) | 0 (0%) | |
| T3 | 64 (12.6%) | 20 (11.5%) | 11 (12.0%) | 0 (0%) | |
| T4 | 12 (2.4%) | 8 (4.6%) | 9 (9.8%) | 0 (0%) | |
| pathologic_M | |||||
| M0 | 351 (69.2%) | 131 (75.3%) | 68 (73.9%) | 0 (0%) | 0.22 |
| M1 | 10 (2.0%) | 6 (3.4%) | 3 (3.3%) | 0 (0%) | |
| MX | 146 (28.8%) | 37 (21.3%) | 21 (22.8%) | 1 (100%) | |
| pathologic_stage | |||||
| Stage I | 387 (76.3%) | 0 (0%) | 0 (0%) | 0 (0%) | <0.001 |
| Stage II | 96 (18.9%) | 140 (80.5%) | 1 (1.1%) | 0 (0%) | |
| Stage III | 10 (2.0%) | 26 (14.9%) | 87 (94.6%) | 1 (100%) | |
| Stage IV | 10 (2.0%) | 6 (3.4%) | 3 (3.3%) | 0 (0%) | |
| Missing | 4 (0.8%) | 2 (1.1%) | 1 (1.1%) | 0 (0%) | |
| Age (years) | |||||
| Mean (SD) | 66.6 (9.59) | 65.4 (9.31) | 64.4 (10.1) | 60.0 (NA) | 0.994 |
| Median [Min, Max] | 68.0 [33.0, 88.0] | 66.0 [41.0, 84.0] | 65.0 [40.0, 87.0] | 60.0 [60.0, 60.0] | |
| Missing | 17 (3.4%) | 7 (4.0%) | 4 (4.3%) | 0 (0%) | |
| gender | |||||
| FEMALE | 217 (42.8%) | 62 (35.6%) | 44 (47.8%) | 1 (100%) | 0.128 |
| MALE | 290 (57.2%) | 112 (64.4%) | 48 (52.2%) | 0 (0%) |